Literature DB >> 1224992

Epidermoid carcinoma of the tongue. Histologic grading in the clinical evaluation.

C Lund, H Sogaard, O Elbrond, K Jorgensen, A P Andersen.   

Abstract

In a series of 49 patients with epidermoic carcinoma of the tongue microscopy of the primary biopsy was performed, using a multifactorial grading system consisting of 8 parameters, each of 4 grades. The score value (degree of malignancy) revealed a statistically significant correlation with the frequency of regional metastases. As this was particularly marked in the T1 and T2 groups, it seems to be an important supplement to the clinical evaluation of risk groups.

Entities:  

Mesh：

Year:  1975        PMID： 1224992     DOI： 10.3109/02841867509132692

Source DB:  PubMed          Journal:  Acta Radiol Ther Phys Biol        ISSN： 0567-8064


  5 in total

1.  Cervical node metastases in early squamous cell carcinoma of the floor of the mouth: predictive value of multiple histopathologic parameters.

Authors:  R W Nason; N B Castillo; K Sako; D P Shedd
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

2.  Relationships of cervical lymph node metastasis to histopathological malignancy grade, tumor angiogenesis, and lymphatic invasion in tongue cancer.

Authors:  Yasuo Okada
Journal:  Odontology       Date:  2010-07-23       Impact factor: 2.634

3.  Vimentin in oral squamous cell carcinoma.

Authors:  V C de Araujo; D S Pinto Júnior; S O de Sousa; F D Nunes; N S de Araujo
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

4.  Worst pattern of invasion in oral squamous cell carcinoma is an independent prognostic factor.

Authors:  Aseem Mishra; Abhishek Das; Ipsita Dhal; Ravi Shankar; B M Bhavya; Neha Singh; Parul Tripathi; Dipti Daga; Atul Rai; Monika Gupta; Guru Charan Sahu
Journal:  J Oral Biol Craniofac Res       Date:  2022-09-08

5.  DNA content, malignancy grading and prognosis in T1 and T2 oral cavity carcinomas.

Authors:  M Tytor; G Franzén; J Olofsson; U Brunk; B Nordenskjöld
Journal:  Br J Cancer       Date:  1987-11       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.